These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 15921723
1. Characterisation of species differences in the platelet ADP and thrombin response. Nylander S, Mattsson C, Lindahl TL. Thromb Res; 2006; 117(5):543-9. PubMed ID: 15921723 [Abstract] [Full Text] [Related]
2. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Cook NS, Zerwes HG, Tapparelli C, Powling M, Singh J, Metternich R, Hagenbach A. Thromb Haemost; 1993 Sep 01; 70(3):531-9. PubMed ID: 8259560 [Abstract] [Full Text] [Related]
3. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Baurand A, Eckly A, Bari N, Léon C, Hechler B, Cazenave JP, Gachet C. Thromb Haemost; 2000 Sep 01; 84(3):484-91. PubMed ID: 11019976 [Abstract] [Full Text] [Related]
4. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets. Bambace NM, Levis JE, Holmes CE. Platelets; 2010 Sep 01; 21(2):85-93. PubMed ID: 20063989 [Abstract] [Full Text] [Related]
9. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets. Mateos-Trigos G, Evans RJ, Heath MF. Platelets; 2002 Mar 01; 13(5-6):285-92. PubMed ID: 12189014 [Abstract] [Full Text] [Related]
10. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets. Martinson EA, Scheible S, Marx-Grunwitz A, Presek P. Thromb Haemost; 1998 Dec 01; 80(6):976-81. PubMed ID: 9869170 [Abstract] [Full Text] [Related]
16. Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activation. Tarnow I, Kristensen AT, Krogh AK, Frelinger AL, Barnard MR, Michelson AD. Vet Immunol Immunopathol; 2008 Jun 15; 123(3-4):345-52. PubMed ID: 18405981 [Abstract] [Full Text] [Related]
17. [Measurement of fibrinogen binding to platelets by flow cytometry: evaluation method for reflecting platelet activation]. Ishikawa S, Tozuka M, Hirota M, Sasaki Y, Okumura N, Furihata K, Katsuyama T. Rinsho Byori; 1998 Jun 15; 46(6):605-10. PubMed ID: 9691771 [Abstract] [Full Text] [Related]
18. Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation. Nylander S, Mattsson C, Ramström S, Lindahl TL. Br J Pharmacol; 2004 Aug 15; 142(8):1325-31. PubMed ID: 15265806 [Abstract] [Full Text] [Related]
19. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets. Bryant J, Post JM, Alexander S, Wang YX, Kent L, Schirm S, Tseng JL, Subramanyam B, Buckman B, Islam I, Yuan S, Sullivan ME, Snider M, Morser J. Thromb Res; 2008 Aug 15; 122(4):523-32. PubMed ID: 18495218 [Abstract] [Full Text] [Related]
20. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor. Dovlatova N, Wijeyeratne YD, Fox SC, Manolopoulos P, Johnson AJ, White AE, Latif ML, Ralevic V, Heptinstall S. Thromb Haemost; 2008 Aug 15; 100(2):261-70. PubMed ID: 18690346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]